Curis
CRIS
#10633
Rank
HK$98.12 M
Marketcap
HK$2.52
Share price
55.98%
Change (1 day)
-86.18%
Change (1 year)

Curis (CRIS) - Cash on Hand

Cash on Hand as of September 2025 : HK$70.98 Million

According to Curis's latest financial reports the company has HK$70.98 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Curis - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$0.15 B-64.71%
2023-12-31HK$0.43 B-34.23%
2022-12-31HK$0.66 B-25.96%
2021-12-31HK$0.90 B-30.82%
2020-12-31HK$1.30 B716.42%
2019-12-31HK$0.15 B-15.82%
2018-12-31HK$0.19 B-59.61%
2017-12-31HK$0.47 B36.42%
2016-12-31HK$0.34 B-45.85%
2015-12-31HK$0.63 B65.08%
2014-12-31HK$0.38 B-14.47%
2013-12-31HK$0.45 B4.8%
2012-12-31HK$0.43 B46.95%
2011-12-31HK$0.29 B-7.28%
2010-12-31HK$0.31 B61.37%
2009-12-31HK$0.19 B-12.19%
2008-12-31HK$0.22 B-31.03%
2007-12-31HK$0.32 B13.39%
2006-12-31HK$0.28 B-16.83%
2005-12-31HK$0.34 B-10.92%
2004-12-31HK$0.38 B40.47%
2003-12-31HK$0.27 B-14.28%
2002-12-31HK$0.31 B-21.35%
2001-12-31HK$0.40 B-30.6%
2000-12-31HK$0.58 B252.65%
1999-12-31HK$0.16 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
HK$102.54 B 144,359.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$82.23 B 115,754.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
HK$0.44 B 520.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$6.09 B 8,486.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$3.54 B 4,887.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
HK$85.9 M 21.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.92 B 2,612.41%๐Ÿ‡บ๐Ÿ‡ธ USA